Phase 1 trial of ibrutinib and carfilzomib combination therapy for relapsed or relapsed and refractory multiple myeloma.
Leuk Lymphoma
; 59(11): 2588-2594, 2018 11.
Article
in En
| MEDLINE
| ID: mdl-29616843
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antineoplastic Combined Chemotherapy Protocols
/
Multiple Myeloma
Type of study:
Clinical_trials
Limits:
Aged80
Language:
En
Journal:
Leuk Lymphoma
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2018
Type:
Article
Affiliation country:
United States